---
title: "Pulse Biosciences to redeem remaining warrants after VWAP triggers; exercise window until July 13, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289332885.md"
description: "Pulse Biosciences will issue an irrevocable notice to redeem its remaining 200% warrants after the VWAP exceeded $22.00 for 20 consecutive days. Warrant holders may exercise their rights until July 13, 2026, at $11.00 per share; unexercised warrants will be redeemed for $0.01. The company has raised $63.7M from prior redemptions and expects up to $2.1M more if remaining warrants are exercised."
datetime: "2026-06-10T13:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289332885.md)
  - [en](https://longbridge.com/en/news/289332885.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289332885.md)
---

# Pulse Biosciences to redeem remaining warrants after VWAP triggers; exercise window until July 13, 2026

**Pulse Biosciences will deliver an irrevocable notice to redeem remaining 200% warrants after VWAP exceeded the trigger, with holders able to exercise until July 13, 2026.**

**Key Highlights:**

-   Company will deliver irrevocable redemption notice for remaining 200% warrants (CUSIP 74587B143) on or about June 10, 2026.
-   Redemption triggered after VWAP exceeded $22.00 for 20 consecutive trading days; average VWAP was $25.17.
-   Holders may exercise warrants for $11.00 per share until 5:00 p.m. ET on July 13, 2026; unexercised warrants will be redeemed for $0.01.
-   Rights offering generated $60.0M; Company has received $63.7M from prior warrant redemptions and could receive $2.1M if remaining warrants are exercised.

Original SEC Filing: PULSE BIOSCIENCES, INC. \[ PLSE \] - 8-K - Jun. 10, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)

## Related News & Research

- [Pulse Biosciences advances NANOPULSE-AF pivotal study enrollment](https://longbridge.com/en/news/294218345.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [Boost Run sets USD 0.01 per warrant redemption, Aug. 20 exercise deadline](https://longbridge.com/en/news/293920690.md)
- [Ciena's Q3 2026 Earnings: What to Expect](https://longbridge.com/en/news/293952665.md)
- [Equatorial Energia updates financial calendar for 2026 disclosures](https://longbridge.com/en/news/294368263.md)